Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics for $17.4M in Cash and $107.6M in BTX Stock


Benzinga | Jun 14, 2021 07:33AM EDT

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics for $17.4M in Cash and $107.6M in BTX Stock






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC